132 related articles for article (PubMed ID: 38724638)
21. Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Patients with Textured Tissue Expanders.
Nelson JA; McKernan CD; Rubenstein RN; Shamsunder MG; Poulton R; Dabic S; Mehrara BJ; Disa JJ; Cordeiro PG; McCarthy CM
Plast Reconstr Surg; 2023 Jul; 152(1):32-37. PubMed ID: 36728202
[TBL] [Abstract][Full Text] [Related]
22. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
23. The Role of Microorganisms in the Development of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Alessandri-Bonetti M; Jeong T; Vaienti L; De La Cruz C; Gimbel ML; Nguyen VT; Egro FM
Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839585
[TBL] [Abstract][Full Text] [Related]
24. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
[TBL] [Abstract][Full Text] [Related]
25. Incidental Bystander or Essential Culprit: A Systematic Review of Bacterial Significance in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Foppiani JA; Raska O; Taritsa I; Hernandez Alvarez A; Lee D; Escobar-Domingo MJ; Berger J; Klener P; Schuster KA; Abdo D; Clemens MW; Lin SJ
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203524
[TBL] [Abstract][Full Text] [Related]
26. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.
Nelson JA; Dabic S; Mehrara BJ; Cordeiro PG; Disa JJ; Pusic AL; Matros E; Dayan JH; Allen RJ; Coriddi M; Polanco TO; Shamsunder MG; Wiser I; Morrow M; Dogan A; Cavalli MR; Encarnacion E; Lee ME; McCarthy CM
Ann Surg; 2020 Sep; 272(3):403-409. PubMed ID: 32694446
[TBL] [Abstract][Full Text] [Related]
27. Textured vs. Smooth Breast Implants Using the Jones Criteria-What Is the Currently Available Evidence for BIA-ALCL?: A Systematic Review.
Hecker A; Giese B; Pignet AL; Schellnegger M; Kamolz LP; Lumenta DB
J Pers Med; 2023 May; 13(5):. PubMed ID: 37240986
[TBL] [Abstract][Full Text] [Related]
28. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
[TBL] [Abstract][Full Text] [Related]
29. Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).
Lee JH
Yeungnam Univ J Med; 2021 Jul; 38(3):175-182. PubMed ID: 33461261
[TBL] [Abstract][Full Text] [Related]
30. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
[TBL] [Abstract][Full Text] [Related]
31. Is Banning Texturized Implants to Prevent Breast Implant-Associated Anaplastic Large Cell Lymphoma a Rational Decision? A Meta-Analysis and Cost-Effectiveness Study.
Danilla SV; Jara RP; Miranda F; Bencina F; Aguirre M; Troncoso E; Erazo CA; Andrades PR; Sepulveda SL; Albornoz CR
Aesthet Surg J; 2020 Jun; 40(7):721-731. PubMed ID: 31761953
[TBL] [Abstract][Full Text] [Related]
32. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
[TBL] [Abstract][Full Text] [Related]
33. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
Fitzal F; Turner SD; Kenner L
Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983
[TBL] [Abstract][Full Text] [Related]
34. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
[TBL] [Abstract][Full Text] [Related]
35. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
[TBL] [Abstract][Full Text] [Related]
36. A Rare Case of BIA-ALCL Mass Associated with Mastectomy Skin Flap Erythema After Immunization with COVID-19.
Garusi C; De Antoni E; Fiori S; Vanazzi A; Pileri SA
Aesthetic Plast Surg; 2023 Feb; 47(1):116-121. PubMed ID: 36380099
[TBL] [Abstract][Full Text] [Related]
37. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in Poland: analysis of patient series and practical guidelines for breast surgeons.
Pluta P; Giza A; Kolenda M; Fendler W; Braun M; Chudobiński C; Chałubińska-Fendler J; Araszkiewicz M; Loga K; Lembas L; Witkowska M; Pluta A; Kolasiński J; Basta P; Kołacińska-Voytkuv A; Cieśla S; Jesionek-Kupnicka D; Jankau J; Kuczyński M; Kalinka E; Zadrożny M; Murawa D
Arch Med Sci; 2023; 19(5):1243-1251. PubMed ID: 37732037
[TBL] [Abstract][Full Text] [Related]
38. Reply: Comment on BIA-ALCL: Comparing the Risk Profiles of Smooth and Textured Breast Implants.
Swanson E
Aesthetic Plast Surg; 2024 Jan; 48(1):19-22. PubMed ID: 37308573
[TBL] [Abstract][Full Text] [Related]
39. Patients' Question-Asking About Breast Implant-Associated Anaplastic Large Cell Lymphoma (BI-ALCL) and Breast Implant Illness (BII): Implementing Questions in BREAST-Q.
Zingaretti N; Mura S; Caputo GG; Parodi PC
Aesthetic Plast Surg; 2022 Oct; 46(5):2618-2620. PubMed ID: 35089386
[TBL] [Abstract][Full Text] [Related]
40. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
Tevis SE; Hunt KK; Miranda RN; Lange C; Butler CE; Clemens MW
Aesthet Surg J; 2019 Sep; 39(10):1065-1070. PubMed ID: 30715139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
